According to these evidences, our in vivo model shows that lower FOXE1 expression leads to the development of less differentiated cancers, which display lower proliferation and higher apoptosis rates, thereby strengthening the possibility that FOXE1 could exert contrasting roles in thyroid neoplastic transformation. This evidence concerns the gene FOXE1 and thyroid gland disorder.